Tuesday, June 8, 2010

As turning into the largest CRO, WuXi PharmaTech is struggling !

June 7, 2010 : The major shareholder, Jana Partners rejects Charles River Purchase of China’s WuXi. Jana head,Barry Rosenstein, said “Even if the contemplated benefits can ultimately be realized, we believe that the high cost, significant integration risks and inopportune timing simply make the proposed acquisition the wrong path for Charles River shareholders.”

Date backs to 2008, Covance surrendered a joint venture plan with WuXi.

Shanghai Jiao-Tong University_how hypoxia regulated lectins

Carcinogenesis. 2010 Jun 4.
Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells.
http://www.ncbi.nlm.nih.gov/pubmed/20525878

Tianjin Medical University_significant correlation between breast Ca & GSTP1

Breast Cancer Res Treat. 2010 Jun 5.
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects.

Data shows that Ile105Val polymorphism increases the susceptibility to breast cancer in Asian population.

Chinese University of Hong Kong_

Breast Cancer Res Treat. 2010 Jun 5. [Epub ahead of print]
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?
http://www.ncbi.nlm.nih.gov/pubmed/20526738

Harbin Medical University_

Breast Cancer Res Treat. 2010 Jun 6.
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.

Data shows this polymorphism is more significant associated with breast cancer in Caucasians rather than in Asians
http://www.ncbi.nlm.nih.gov/pubmed/20526805

National Taiwan University_microRNA regulated protein is associated with liver cancer

Carcinogenesis. 2010 Jun 4.
Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.
http://www.ncbi.nlm.nih.gov:80/pubmed/20525879

Harbin Pharmaceuticals acquired Pfizer animal vaccine biz

Pfizer sells animal vaccine business (a deal worth of 50 million U.S. dollars) to Harbin Pharmaceuticals

09:16, June 01, 2010

http://english.peopledaily.com.cn/90001/90778/90860/7007156.html
alveice Team. Powered by Blogger.